Tanzania- CDC 16 (4982) P3 Labelling and marking of pharmaceutical products – Specification

ThisStandardspecifiesgeneralmandatory andoptionalrequirements ofalabel for pharmaceutical products.It alsogives requirements for secondary packaging or where there is no secondary packaging, primary packaging, small containers, blisters and strips.

Proposed date of adoption: August 2017

Proposed date of entry into force: Upon declaration as a mandatory Standard by Minister for Industry, Trade and Investment

Final date for comments: 60 days after circulation by WTO secretariat

If the Proposal/Notification/Regulation will affect your International Business please send us your representation with facts and figures , so that these can be taken up suitably.